
New clinical trial could offer a functional cure for people with type 1 diabetes
New clinical trial could offer a functional cure for people with type 1 diabetes
New clinical trial could offer a functional cure for people with type 1 diabetes
The ViaCyte trial is being run at three sites in North America, including University of Minnesota Health.
Greg Romero (right) has to live with his type 1 diabetes all day, every day. But a new clinical trial offered through University of Minnesota Health could give him a functional cure for his disease.
Greg Romero cant run or hide from his type 1 diabetes .
Its the main priority I have, taking care of this disease, he said. Every minute of every day.
Romero has been diabetic since he was 11 years old, but in the past several years his disease has become more complicated. Hes developed hypoglycemia unawareness, which means hes not able to feel when his blood glucose drops to dangerously low levels. Even with new technology that routinely provides him insulin and monitors his blood glucose levels, managing his disease is an ever-present responsibility.
Now, theres a sign of hope. Romero is one of a handful of people in the world participating in a new clinical trial thats studying whether pancreatic progenitor cells, transplanted into a person with type 1 diabetes, can become cells that produce insulin naturallyeffectively curing the disease. Developed by ViaCyte, the trial is available at three sites in North America, including University of Minnesota Health.
Learn more about University of Minnesota Health diabetes care.
These pancreatic progenitor cells are a renewable resource. A single progenitor cell
Continue
reading